Amedisys SG&A Expenses 2010-2024 | AMED

Amedisys sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Amedisys Annual SG&A Expenses
(Millions of US $)
2023 $780
2022 $754
2021 $711
2020 $668
2019 $608
2018 $501
2017 $482
2016 $503
2015 $452
2014 $442
2013 $474
2012 $517
2011 $507
2010 $543
2009 $493
Amedisys Quarterly SG&A Expenses
(Millions of US $)
2024-09-30 $142
2024-06-30 $137
2024-03-31 $193
2023-12-31 $316
2023-09-30 $136
2023-06-30 $135
2023-03-31 $194
2022-12-31 $193
2022-09-30 $188
2022-06-30 $188
2022-03-31 $184
2021-12-31 $185
2021-09-30 $179
2021-06-30 $175
2021-03-31 $172
2020-12-31 $176
2020-09-30 $180
2020-06-30 $156
2020-03-31 $157
2019-12-31 $156
2019-09-30 $155
2019-06-30 $152
2019-03-31 $145
2018-12-31 $132
2018-09-30 $125
2018-06-30 $123
2018-03-31 $121
2017-12-31 $124
2017-09-30 $119
2017-06-30 $121
2017-03-31 $119
2016-12-31 $125
2016-09-30 $124
2016-06-30 $127
2016-03-31 $128
2015-12-31 $120
2015-09-30 $113
2015-06-30 $116
2015-03-31 $104
2014-12-31 $104
2014-09-30 $103
2014-06-30 $108
2014-03-31 $126
2013-12-31 $117
2013-09-30 $116
2013-06-30 $118
2013-03-31 $124
2012-12-31 $125
2012-09-30 $127
2012-06-30 $131
2012-03-31 $134
2011-12-31 $115
2011-09-30 $135
2011-06-30 $127
2011-03-31 $130
2010-12-31 $117
2010-09-30 $147
2010-06-30 $144
2010-03-31 $134
2009-12-31 $117
2009-09-30 $132
2009-06-30 $127
2009-03-31 $117
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.744B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00